Financial Performance - The company reported a significant negative retained earnings of -578,299,522.42 CNY for the parent company and -625,383,089.08 CNY for the consolidated entity, indicating substantial unaddressed losses [4]. - The board of directors confirmed that no cash dividends will be distributed for the fiscal year 2025 due to the company's financial situation, highlighting a risk of prolonged inability to implement cash dividends [5]. - The company's operating revenue for 2025 was ¥520,999,510.02, representing a 17.61% increase from ¥443,007,956.50 in 2024 [18]. - The net profit attributable to shareholders for 2025 was -¥35,803,143.82, an improvement of 65.91% compared to -¥105,034,809.41 in 2024 [18]. - The net cash flow from operating activities for 2025 was ¥14,152,190.40, a significant increase of 1,540.13% from -¥982,703.47 in 2024 [18]. - The total assets at the end of 2025 amounted to ¥1,070,867,956.16, which is an increase of 78.81% from ¥598,900,538.00 at the end of 2024 [18]. - The net assets attributable to shareholders at the end of 2025 were ¥451,157,254.02, showing a remarkable increase of 796.13% from -¥64,809,147.62 at the end of 2024 [18]. - The basic earnings per share for 2025 was -¥0.1108, reflecting a 65.90% improvement from -¥0.3249 in 2024 [18]. - The company reported a quarterly revenue of ¥168,380,841.77 in Q4 2025, with a net profit of ¥2,331,657.30 attributable to shareholders [24]. Operational Efficiency - The company experienced a significant increase in revenue from non-core business activities, generating ¥2,503,672.59 in 2025 compared to ¥5,621,681.42 in 2024 [19]. - The weighted average return on equity for 2025 was 143.29%, indicating a recovery from -114.57% in 2024 [18]. - The company has undergone multiple changes in controlling shareholders, with the latest being Beijing Xingrui Qiyuan Technology Co., Ltd. holding 15.47% of the total shares as of the report date [16]. - The company has a total design capacity of 20,450 tons for pyridine products and 500 tons for nitrification products, both of which are currently operational [30]. - The company operates in a chemical park with a focus on large-scale petrochemical and coal chemical industries, covering an area of 40 square kilometers [30]. - The company primarily produces pyridine and nitration products, which are essential for the agricultural, pharmaceutical, and feed additive industries [41]. Research and Development - The company holds 75 utility model patents and several invention patents, indicating a strong focus on R&D and innovation in production technology [30]. - The company has developed 7 invention patents and 13 utility model patents, showcasing its strong R&D capabilities in the fine chemical industry [46]. - Research and development expenses increased by 4.37% to 14,383,723.69 CNY in 2025 [64]. - The company is focusing on optimizing the separation process of 3-cyanopyridine, aiming to improve yield and product quality [65]. - The company is advancing the project for the synthesis of 2-chloronicotinic acid according to plan, focusing on optimizing process conditions [66]. Market Position and Strategy - The company is strategically positioned to leverage the growing market for agricultural and pharmaceutical chemicals, which are expected to expand further in the coming years [34]. - The company is focused on developing a high-end pharmaceutical ecosystem, including APIs, intermediates, and modern Chinese medicine, within a 26 square kilometer area in the Cangzhou Bohai New Area [31]. - The company is considering strategic acquisitions to bolster its technology portfolio, with a budget of $30 million allocated for potential deals [125]. - The company plans to strengthen market expansion and improve operational capabilities in 2026 [154]. Governance and Compliance - The company has implemented an internal control system and established an internal audit department to ensure operational quality and compliance [109]. - The company emphasizes effective communication with shareholders, providing platforms for engagement and feedback [110]. - The company has committed to timely and accurate information disclosure, ensuring all shareholders have equal access to information [110]. - The company has a clear governance structure that aligns with regulatory requirements, with no significant discrepancies noted [111]. - The company held 5 shareholder meetings and 1 investor group meeting during the reporting period, ensuring compliance with governance regulations [107]. Financial Management - The company reported a significant cash balance of ¥398.45 million in the management account during the restructuring period [75]. - The net increase in cash and cash equivalents for 2025 was ¥76,799,903.31, a significant rise of 5,527.72% compared to ¥1,364,671.99 in 2024 [71]. - The company is facing potential delisting risks and is actively discussing measures to address this issue [96]. - The company is exploring changes in business scope, particularly in relation to rare earth processing operations [96]. - The company is committed to maintaining independence in its operations, ensuring no interference from related parties in business activities [169]. Shareholder Engagement - Shareholder engagement is a priority, with multiple communications regarding shareholder meetings and participation [96]. - The company is actively consulting on shareholder numbers, with inquiries made on multiple dates in June and July 2025 [97][98]. - The company is addressing concerns related to its financial health and market position through strategic communications [95]. - The company is currently undergoing restructuring and is in the process of updating shareholders on the progress as of November 2025 [100]. Environmental Compliance - The company has established a comprehensive environmental compliance framework, including wastewater and air emission permits, ensuring sustainable operations [31]. - The company adheres to green development principles, ensuring compliance with environmental laws and regulations during production [162]. - The company has fully complied with environmental information disclosure requirements, with one subsidiary included in the legally mandated disclosure list [161]. Employee Management - The total number of employees at the end of the reporting period is 412, with 22 in the parent company and 390 in major subsidiaries [148]. - The company has implemented a performance-based compensation system, which includes both fixed and variable components to motivate employees [150]. - In 2025, the company will continue to enhance training for new employees and key positions to ensure compliance and protect minority investors' interests [151].

公司代码：600419 公司简称：天润乳业 债券代码：110097 债券简称：天润转债 新疆天润乳业股份有限公司 2025 年年度报告 新疆天润乳业股份有限公司2025 年年度报告 重要提示 一、本公司董事会及董事、高级管理人员保证年度报告内容的真实性、准确性、完整性，不存在 虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 二、公司全体董事出席董事会会议。 三、中审众环会计师事务所（特殊普通合伙）为本公司出具了标准无保留意见的审计报告。 四、公司负责人刘让、主管会计工作负责人王慧玲及会计机构负责人（会计主管人员）牟芹芹 声明：保证年度报告中财务报告的真实、准确、完整。 五、董事会决议通过的本报告期利润分配预案或公积金转增股本预案 （1）公司拟向全体股东每股派发现金红利0.02元（含税）。截至2026年3月29日，公司总股 本315,512,123股，拟派发现金红利6,310,242.46元（含税），占当年归属于上市公司股东的净利润 比例为15.21%。 （2）2025年度公司不送红股，亦不进行资本公积金转增股本。 如在公司2025年度利润分配方案公告披露之日起至实施权益分派股权登记日期间，公司享 ...

凯盛科技股份有限公司 2025 年年度报告 公司代码：600552 公司简称：凯盛科技 凯盛科技股份有限公司 2025 年年度报告 1 / 156 凯盛科技股份有限公司 2025 年年度报告 重要提示 一、本公司董事会及董事、高级管理人员保证年度报告内容的真实性、准确性、完整性，不存在 虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 二、公司全体董事出席董事会会议。 三、 致同会计师事务所（特殊普通合伙）为本公司出具了标准无保留意见的审计报告。 四、公司负责人夏宁、主管会计工作负责人陈幸及会计机构负责人（会计主管人员）李淑娟声明： 保证年度报告中财务报告的真实、准确、完整。 五、 董事会决议通过的本报告期利润分配预案或公积金转增股本预案 以实施权益分派股权登记日的总股本为基数，向全体股东每10股派发现金红利0.50元（税前）。 截至报告期末，母公司存在未弥补亏损的相关情况及其对公司分红等事项的影响 □适用 √不适用 六、 前瞻性陈述的风险声明 √适用 □不适用 本报告涉及的发展战略、经营计划等前瞻性陈述受市场状况变化等多方面因素影响，并不构成公 司对投资者的实质承诺，提请广大投资者注意投资风险。 ...

凯盛新能源股份有限公司2025 年年度报告 公司代码：600876 公司简称：凯盛新能 凯盛新能源股份有限公司 2025 年年度报告 1 / 213 凯盛新能源股份有限公司2025 年年度报告 重要提示 一、本公司董事会及董事、高级管理人员保证年度报告内容的真实性、准确性、完整性， 不存在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 经致同会计师事务所（特殊普通合伙）出具的审计报告确认，公司2025年实现合并净利 润-982,732,432.85元，其中归属于母公司所有者的净利润-914,340,285.27元。母公司2025年 实现净利润6,675,861.30元，截止2025年末累计未分配利润为-647,750,718.87元。经董事会决 议，公司2025年度不进行利润分配，也不进行资本公积转增股本和其他形式的利润分配。 本报告期利润分配预案尚需股东会批准。 截至报告期末，母公司存在未弥补亏损的相关情况及其对公司分红等事项的影响 √适用 □不适用 经致同会计师事务所（特殊普通合伙）出具的审计报告确认，截至2025年12月31日，母 公司累计未分配利润-647,750,718.87元，存在未 ...

石大胜华新材料集团股份有限公司2025 年年度报告 公司代码：603026 公司简称：石大胜华 一、本公司董事会、监事会及董事、监事、高级管理人员保证年度报告内容的真实性、准确性、 完整性，不存在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 二、公司全体董事出席董事会会议。 三、立信会计师事务所（特殊普通合伙）为本公司出具了标准无保留意见的审计报告。 四、公司负责人郭天明、主管会计工作负责人宋会宝及会计机构负责人（会计主管人员）贾少山 声明：保证年度报告中财务报告的真实、准确、完整。 五、董事会决议通过的本报告期利润分配预案或公积金转增股本预案 石大胜华新材料集团股份有限公司 2025 年年度报告 1 / 252 石大胜华新材料集团股份有限公司2025 年年度报告 重要提示 2 / 252 石大胜华新材料集团股份有限公司2025 年年度报告 2025年度利润分配预案为：以2025年12月31日公司总股本232,701,014.00 股为基数，向全体 股东每 10 股派现金股利0.40 元（含税），共计派发现金股利 9,308,040.56 元。 公司 2025 年度不进行资本公积金转增股本。 ...

三生国健药业（上海）股份有限公司 2025 年年度报告 公司代码：688336 公司简称：三生国健 三生国健药业（上海）股份有限公司 2025 年年度报告 1 / 228 三生国健药业（上海）股份有限公司 2025 年年度报告 重要提示 一、本公司董事会及董事、高级管理人员保证年度报告内容的真实性、准确性、完整性，不存在 虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 二、公司上市时未盈利且尚未实现盈利 □是 √否 三、重大风险提示 公司已在本报告中详细阐述公司核心竞争力风险、经营风险及行业风险等风险因素，敬请查 阅本报告第三节"管理层讨论与分析"之"风险因素",并提请投资者特别关注如下风险： 1、创新药研发面临不确定性以及较大市场竞争的风险 创新药研发具有研发周期长、投入大、风险高、成功率低的特点，从立项到新药获批上市要 经过临床前研究、临床试验、新药注册上市和售后监督等诸多复杂环节，每一环节都有可能面临 失败风险。另外，考虑到药物研发风险以及未来产品上市面临市场竞争的不确定性，若公司无法 有效利用自身的研发技术经验、规模化生产优势或终端销售覆盖能力，则可能导致在研产品无法 在同靶点产品中抢先 ...

中储发展股份有限公司2025 年年度报告 公司代码：600787 公司简称：中储股份 中储发展股份有限公司 2025 年年度报告 1 / 334 中储发展股份有限公司2025 年年度报告 重要提示 一、本公司董事会及董事、高级管理人员保证年度报告内容的真实性、准确性、完整性，不存在 虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 二、公司全体董事出席董事会会议。 三、信永中和会计师事务所（特殊普通合伙）为本公司出具了标准无保留意见的审计报告。 四、公司负责人房永斌、主管会计工作负责人武凯及会计机构负责人（会计主管人员）赵鹏声明： 保证年度报告中财务报告的真实、准确、完整。 五、董事会决议通过的本报告期利润分配预案或公积金转增股本预案 2026年3月27日，公司十届六次董事会审议通过了《公司2025年年度利润分配方案》，公司拟 以实施权益分派股权登记日登记的总股本为基数，每10股派发现金红利1.13元（含税）。 截至报告期末，母公司存在未弥补亏损的相关情况及其对公司分红等事项的影响 七、是否存在被控股股东及其他关联方非经营性占用资金情况 否 八、是否存在违反规定决策程序对外提供担保的情况 否 九、 ...

Company Vision and Strategy - The company aims to become a leading global financial institution, focusing on building an international first-class investment bank in China[5]. - The company is committed to high-quality development and aims to establish itself as a leading investment bank, focusing on strategic planning and organizational transformation[41]. - The company aims to become one of the "2 to 3 internationally competitive investment banks and institutions" and is focused on providing comprehensive financial services globally[103]. - The company is focused on enhancing its cross-border trading capabilities and expanding into emerging markets and Belt and Road countries to attract foreign investment[133]. - The company is actively pursuing mergers and acquisitions, including the absorption of Dongxing Securities and Xinda Securities, aiming for synergistic effects[41]. Financial Performance - The financial report indicates a significant increase in revenue, with a year-over-year growth of 15% to reach RMB 10 billion[12]. - Total revenue for 2025 reached RMB 28.48 billion, a 33.50% increase from RMB 21.33 billion in 2024[81]. - Net profit attributable to shareholders for 2025 was RMB 9.79 billion, reflecting a 71.93% growth compared to RMB 5.69 billion in 2024[81]. - Operating cash flow for 2025 was RMB 71.08 billion, a significant increase of 69.74% from RMB 41.87 billion in 2024[81]. - The company achieved a 99% profitability rate for all managed accounts that have been established for over a year[43]. Market Presence and Expansion - The company is expanding its market presence in Southeast Asia, with plans to open three new offices by the end of 2025[12]. - The company has established subsidiaries or branches in international markets including Hong Kong, New York, London, Singapore, Frankfurt, Tokyo, Vietnam, and Dubai[59]. - The company has expanded its market presence by assisting Jiaxin International Resources in dual listings in Hong Kong and Kazakhstan[43]. - The company has a balanced business layout, focusing on traditional investment banking and emerging sectors like asset management and private equity[107]. Product Development and Innovation - New product launches include a digital wealth management platform, expected to enhance user engagement and drive additional revenue streams[12]. - The company has invested RMB 500 million in research and development for innovative financial technologies[12]. - The company plans to enhance its service capabilities for medium-sized projects and strengthen its influence in large projects in the A-share market in 2026[119]. - The company aims to increase resource investment in REITs business and expand asset management scale and stable management income in 2026[123]. Risk Management and Compliance - The company emphasizes risk management across various dimensions, including market, credit, liquidity, operational, and compliance risks[27]. - The company has a structured governance framework in compliance with relevant laws and regulations[60]. - The company will continue to optimize its risk management system and ensure compliance to maintain stable business operations in 2026[144]. Awards and Recognition - The company received the title of "Best Investment Bank" in the 2025 awards by multiple organizations, highlighting its strong market position[69]. - The company ranked 1st in the "Best Local Broker" category in the 2025 Asia Best Local Broker Awards[69]. - The company was recognized as the "Best Wealth Management Institution" in the 2025 Wealth Management Huazun Awards[72]. - The company was awarded the "Best ESG Practice Employer" by Forbes in 2025, reflecting its commitment to sustainable practices[70]. Client Engagement and Social Responsibility - User data shows a 20% increase in active clients, totaling 1.2 million users by the end of the reporting period[12]. - The company actively engaged in social responsibility initiatives, purchasing nearly RMB 12 million in products to support rural revitalization efforts[44]. - The company has established a digital platform, RITAS, to enhance the efficiency and quality of its advisory services[43]. Financial Metrics and Ratios - The company has achieved a net capital ratio of 15%, exceeding regulatory requirements and ensuring financial stability[12]. - The weighted average return on equity for 2025 was 9.39%, an increase of 3.88 percentage points from 5.52% in 2024[83]. - Basic earnings per share for 2025 were RMB 1.876, an 81.15% increase from RMB 1.035 in 2024[83]. - The liquidity coverage ratio for 2025 was 259.74%, down from 293.64% in 2024[88]. Asset Management and Investment - The company’s asset management business scale reached RMB 596.92 billion, with a management scale of RMB 198.65 billion for collective asset management plans and RMB 398.28 billion for single asset management plans[139]. - The private equity investment fund AUM increased by 20% to RMB 420.424 billion in 2025, up from RMB 351.643 billion in 2024[150]. - The wealth management business achieved a product retention scale exceeding RMB 460 billion, marking six consecutive years of positive growth[153]. - The company plans to deepen its core investment research capabilities and enhance its product layout to meet diverse asset allocation needs in 2026[140]. Mergers and Acquisitions - In 2025, the company announced 64 M&A transactions with a total value of approximately $82.08 billion, including 53 domestic transactions worth about $72.96 billion and 11 cross-border transactions totaling around $9.12 billion[125]. - The company is focused on expanding its market presence through strategic mergers and acquisitions[196]. - The board approved a merger plan with Dongxing Securities and Cinda Securities, which was signed on December 17, 2025[196].

吉林泉阳泉股份有限公司2025 年年度报告 公司代码：600189 公司简称：泉阳泉 2025 年年度报告 1 / 259 吉林泉阳泉股份有限公司 吉林泉阳泉股份有限公司2025 年年度报告 重要提示 一、本公司董事会及董事、高级管理人员保证年度报告内容的真实性、准确性、完整性，不 存在虚假记载、误导性陈述或重大遗漏，并承担法律责任。 二、公司全体董事出席董事会会议。 三、大华会计师事务所（特殊普通合伙）为本公司出具了标准无保留意见的审计报告。 四、公司负责人王怀波、主管会计工作负责人白刚及会计机构负责人（会计主管人员）白刚 声明：保证年度报告中财务报告的真实、准确、完整。 五、董事会决议通过的本报告期利润分配预案或公积金转增股本预案 2025年度公司合并会计报表实现归属于上市公司股东的净利润15,078,775.12元。截至2025 年12月31日，累计可供分配利润为-1,462,788,314.06元。其中，母公司会计报表2025年度实现净 利润-20,253,634.22元，根据《公司法》和《公司章程》的规定不需提取法定盈余公积金，加上 以前年度结转未分配利润-2,077,867,312.20元，母公司 ...

恒拓开源 920415 恒拓开源信息科技股份有限公司 （Forever Opensource Software Inc.） 2025 年度报告 1 公司年度大事记 报告期内，公司取得包括恒拓智 能飞行计划平台 V1.0、航空运行控 制全流程管理系统 V1.0 等 35 项计算 机软件著作权登记证书。 恒拓开源于 11 月 21 日重磅亮相 公司员工持股计划第二期考核全 维度达标，锁定期顺利届满并完成合 规披露，股权激励效能充分落地。 2025 年 5 月 27 日，公司以股权 登记日应分配股数 139,455,198 股为 基数，向参与分配的股东每 10 股派 0.35 元人民币现金，本次权益分派 共计派发现金红利 4,880,931.93 元。 2025 湖南（国际）通用航空及低空 经济产业博览会，成功斩获"低空创 新奖"，充分彰显了恒拓开源在低空 数智化领域的技术硬实力！ 2 | 第一节 | 重要提示、目录和释义 4 | | --- | --- | | 第二节 | 公司概况 6 | | 第三节 | 会计数据和财务指标 8 | | 第四节 | 管理层讨论与分析 12 | | 第五节 | 重大事件 48 | ...